Related Experiment Videos
Severe vulvovaginitis associated with intravaginal nystatin therapy
1Clinic for Genitourinary Infections, Infectious Diseases Unit, E Wolfson Hospital, Holon 58100, Israel.
American Journal of Obstetrics and Gynecology
|August 3, 2001
Abstract:
A 64-year-old woman had severe vulvovaginitis develop while she was receiving intravaginal nystatin therapy for Candida glabrata infection. Mucocutaneous adverse effects have rarely been reported with nystatin despite long years of use. This complication should be included in the differential diagnosis of clinical failure of intravaginal nystatin therapy.